They don't make for the prettiest of manicures, but are they something more than a cosmetic problem? Here's what a dermatologist and research have to say. The post Here’s What It Means If You Have ...
Data from Phase I/II SOHO-01 trial presented at 2024 World Conference on Lung Cancer Investigational BAY 2927088 is an oral, small molecule, tyrosine kinase inhibitor as a potential new targeted ...
Johnson & Johnson (NYSE:JNJ) today announced new data from the Phase 1b/2 OrigAMI-1 study, which showed RYBREVANT® (amivantamab-vmjw) combined with chemotherapy (mFOLFOX6 [FOLFOX] or FOLFIRI) ...
Updated data show consistent objective response rate of 40% and manageable safety profile in patients with non-small cell lung cancer harboring epidermal growth factor receptor exon 20 insertion mutat ...